Nov 14 (Reuters) - Prometic Life Sciences Inc PLI.TO :
* Prometic Life Sciences - PBI-4050 shown to reduce pulmonary hypertension and lung remodeling and to improve right ventricular function in heart failure
* Prometic Life Sciences - PBI-4050 did not adversely affect healing of left ventricle, observed some improvement in left ventricular function Source text for Eikon: Further company coverage: PLI.TO